Novavax (NVAX) Stock Chart & Stock Price History $7.68 -0.06 (-0.78%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Novavax Stock Price Performance The Novavax (NVAX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 48.07%, with a year-to-date return of -4.48%. In the past month, the stock has increased 28.00%, reflecting recent market activity. As of the latest close, Novavax traded at $7.74 with a market cap of $1.25 billion and volume of 83.87 million shares. Five years ago, the stock traded at $52.81, representing a 85.46% decrease over that period. At the time, it had a market cap of $3.30 billion and a volume of 8.16 million shares. Receive NVAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novavax and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+22.10%1 Month Performance+28.00%3 Month Performance-3.03%Year-To-Date Performance-4.48%1 Year Performance-48.07%5 Year Performance-85.46% NVAX Stock Chart for Tuesday, May, 20, 2025 NVAX Chart by TradingView Novavax Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/20/2025$7.74$7.68-0.78%$8.24$7.3622.96 million shs$1.24 billion05/19/2025$6.73$7.74+15.01%$8.78$7.1283.87 million shs$1.25 billion05/16/2025$6.29$6.73+7.00%$6.89$6.338.75 million shs$1.09 billion05/15/2025$5.96$6.29+5.54%$6.36$5.969.98 million shs$1.01 billion05/14/2025$6.19$5.96-3.72%$6.28$5.878.50 million shs$958.63 million05/13/2025$6.34$6.19-2.37%$6.46$6.185.62 million shs$995.62 million05/12/2025$5.99$6.34+5.84%$6.45$6.0410.24 million shs$1.02 billion05/09/2025$6.64$5.99-9.73%$6.64$5.8019.97 million shs$963.46 million05/08/2025$5.95$6.64+11.53%$7.50$6.4836.78 million shs$1.07 billion05/07/2025$6.07$5.95-1.98%$6.11$5.924.50 million shs$957.02 million Get the Latest News and Ratings for NVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novavax and its competitors with MarketBeat's FREE daily newsletter. 05/06/2025$6.27$6.07-3.19%$6.45$5.8210.97 million shs$976.32 million05/05/2025$6.41$6.27-2.18%$6.61$6.263.64 million shs$1.01 billion05/02/2025$6.41$6.41$6.58$6.383.63 million shs$1.03 billion05/01/2025$6.67$6.41-3.90%$6.66$6.285.62 million shs$1.03 billion04/30/2025$6.42$6.67+3.89%$6.76$6.245.23 million shs$1.07 billion04/29/2025$6.70$6.42-4.18%$6.71$6.395.05 million shs$1.03 billion04/28/2025$6.67$6.70+0.45%$7.35$6.665.69 million shs$1.08 billion04/25/2025$7.07$6.67-5.66%$7.17$6.1213.15 million shs$1.07 billion04/24/2025$7.48$7.07-5.53%$7.49$6.946.39 million shs$1.14 billion04/23/2025$6.25$7.48+19.74%$7.81$6.9914.73 million shs$1.20 billion04/22/2025$6.01$6.25+3.99%$6.29$6.043.91 million shs$1.01 billion04/21/2025$6.00$6.01+0.17%$6.27$5.873.99 million shs$966.67 million Related Companies BioCryst Pharmaceuticals Stock Price Chart Ligand Pharmaceuticals Stock Price Chart Amicus Therapeutics Stock Price Chart MannKind Stock Price Chart Celldex Therapeutics Stock Price Chart Dynavax Technologies Stock Price Chart Innoviva Stock Price Chart OPKO Health Stock Price Chart Geron Stock Price Chart Regulus Therapeutics Stock Price Chart Receive NVAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novavax and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NVAX) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVAX Stock Free NVAX Stock Alerts